0001209191-13-027552.txt : 20130520 0001209191-13-027552.hdr.sgml : 20130520 20130520162222 ACCESSION NUMBER: 0001209191-13-027552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130516 FILED AS OF DATE: 20130520 DATE AS OF CHANGE: 20130520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 13858644 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-05-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2013-05-16 5 G 0 E 10352 0.00 D 0 I Shares held by GRATS Common Stock 5568 I Revocable Trusts Common Stock 4770 I 401(k) Common Stock 144400 D On May 16, 2013, grantor retained annuity trusts (GRATS) established by Dr. Mueller in 2010 that held 15,920 shares of common stock terminated in accordance with the terms of the GRATs. 10,352 shares were transferred to a trust established for the benefit of Dr. Mueller's adult child. The remaining 5,568 shares were distributed to revocable trusts established for the benefit of Dr. Mueller and his wife and are reported on this Form 4 as indirectly owned. Kenneth L. Horton, Attorney-In-Fact 2013-05-20